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ABSTRACT
Introduction: Few population-based data are
available evaluating the prevalence of lower
urinary tract symptoms (LUTS) in Asia. The
objective of our study was to determine LUTS
prevalence in China, Taiwan, and South Korea
using International Continence Society (ICS)
2002 criteria.
Methods: An Internet-based self-administered
survey among individuals aged at least 40 years
with the ability to use a computer and to read
the local language. Survey questions included
ICS symptom definitions and the international
prostate symptom score (IPSS). Data analysis
was based on descriptive statistics and post hoc
significance testing.
Results: There were 8284 participants, of
whom 51% were women and 34% were aged at
least 60 years. LUTS prevalence was slightly
higher in men than women (62.8% vs. 59.6%;
p = 0.004), increasing significantly with age
(p = 0.001). All three ICS symptom groups
(voiding, storage, and post-micturition) were
present in 35% of individuals with LUTS.
Symptoms with the highest overall prevalence
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were nocturia, frequency, incomplete empty-
ing, and terminal dribble. The most bothersome
symptoms were terminal dribble, nocturia, and
urgency. According to IPSS scores, 87% of par-
ticipants had at least mild symptoms; 43% of
those aged over 60 years had moderate/severe
symptoms. The percentage of participants with
any LUTS who had visited healthcare profes-
sionals because of urinary symptoms was 26%,
rising to 45% amongst individuals with all three
symptom groups (p = 0.001 vs. other ICS
symptom groups).
Conclusions: LUTS are highly prevalent in men
and women aged at least 40 years who partici-
pated in this study in China, Taiwan, and South
Korea and increases with increasing age. A
minority of individuals with LUTS seek health-
care and our results suggest an increased patient
awareness of LUTS is required.
Funding: Astellas Pharma Singapore Pte. Ltd.
Trial registration: ClinicalTrials.gov identifier,
NCT02618421.
Keywords: China; Lower urinary tract
symptoms; Prevalence; Republic of Korea;
Taiwan; Urology
INTRODUCTION
Lower urinary tract symptoms (LUTS) include a
variety of storage, voiding, and post-micturition
symptoms [1, 2]. Both overactive bladder symp-
tom complex (OAB; urinary urgency, with or
without urgency incontinence, usually with
increased urinary frequency and nocturia) and
stress incontinence comprise the main storage
symptoms; voiding symptoms include slow or
interrupted stream, terminal dribble, hesitancy
and straining; while incomplete emptying and
post-micturition dribble are the key post-mic-
turition symptoms. In men, symptoms may be
related to prostate dysfunction, bladder dysfunc-
tion, other structural or functional abnormalities
of the urinary tract and surrounding tissues, or
non-urological conditions (e.g.,nocturia) [3].This
multifactorial etiology of LUTS inmen is reflected
in the different pharmacological agents used to
manage symptoms, which include alpha-adren-
ergic blocking agents, 5-alpha reductase inhibi-
tors, and phosphodiesterase 5 inhibitors [3]. OAB
tends to be viewed as the main cause of LUTS in
women and is recognized as themost bothersome
component of male LUTS. In both sexes, OAB
generally responds to anticholinergic medica-
tions or the b3-adrenergic agonist mirabegron [4].
LUTS affect a significant proportion of adults
and are associated with impaired quality of life
(QoL) [5–7]. LUTSprevalence from large studies in
Europe and North America exceeds 60%, with a
slightly higher overall prevalence in women than
men [8, 9]. However, prevalence is age-related
and, over the age of 70 years, LUTS are more
common in men than women although urinary
incontinence remains more prevalent in women
[9]. Recognition of LUTS has increased in both
sexes in recent years, including underactive
bladder among those aged over 60 years. The
EpiLUTS study showed that symptoms are often
bothersome: at least half of participants with
symptoms occurring at least ‘‘sometimes’’ were
bothered ‘‘somewhat’’ or more [8]. In Asia, few
such population-based studies have been per-
formed [10, 11], symptomdefinitions have varied
between studies [9], and no international study
has been performed in both men and women in
Asia using the symptom definitions recom-
mended by the International Continence Society
(ICS) in 2002 [1]. Consequently, our understand-
ing of the true burden of LUTS in Asia is limited.
We performed this study to evaluate for the
first time the overall prevalence of LUTS in adults
aged at least 40 years in China, Taiwan, and
South Korea, using ICS symptom definitions [1].
METHODS
Study Design and Population
This was a cross-sectional, population-repre-
sentative, Internet-based study conducted
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among men and women aged at least 40 years
in China, Taiwan, and South Korea between
June 2, 2015 and July 20, 2015. Ability to access
the Internet, to use a computer (with help, if
required), and to read the local language were
inclusion criteria. Participants who were preg-
nant at the time of the survey or who had a
urinary tract infection within the preceding
month were excluded.
As this study was based on a survey, it was
not considered necessary to submit for
institutional review board approval. However,
principles of the Declaration of Helsinki were
followed; the study was performed in compli-
ance with Good Clinical Practice and market
research guidelines (Appendix 1 in the online
supplementary material). All participants pro-
vided informed consent before participating in
the study.
Prior to use, quality checks and analysis were
undertaken during six cycles of survey testing
using a team of researchers with a healthcare
background. Participants were selected via
consumer survey panels (e-mail invitations
automatically randomized to prevalidated indi-
viduals) that were actively managed to repre-
sent the target population, with respect to age,
sex, and socioeconomic factors. Cohort man-
agement accounted for sex, income, age group,
and geography, with the last of these restricted
to urban areas. Participants received a secure
link and log-in details to access the survey and
had to provide informed consent before they
could start to answer questions. Weekly remin-
ders were sent during the survey timeframe to
those who had not completed the survey. The
questionnaire was over a total of 111 screens,
including the informed consent page. Selection
of one response was enforced for all questions
apart from the optional section concerning
sexual health. While undertaking the survey
and before submission of the completed survey
respondents were able to review and change
their answers using a back button.
Proprietary algorithms and browser fin-
ger-printing technology involving IP address
recognition were used to block the same person
from responding multiple times to the survey
by using different user credentials (avoiding the
need to analyze log file data) and for anyone
proceeding too fast through the survey (com-
pletion time less than 30% of the median length
of the survey). De-identification of data was
undertaken, with only a numerical identifica-
tion available for analysis. Checking for con-
tradictory answers was completed by healthcare
analysts’ post-data collection and all responses
were valid.
Endpoints
A sample of the survey is presented in the
online supplementary material (Appendix 2).
Participants were asked eight screening and
general demographic questions, including sex,
age, marital status, level of education, and
employment status. Nine questions were used
to evaluate general health and medical comor-
bidities. For some personal questions, such as
marital status, respondents were given the
option not to answer. Instruments/topics
included the international prostate symptom
score (IPSS), other ICS symptoms questions (re-
lated to splitting/spraying, hesitancy, terminal
dribble, urgency), and the patient perception of
bladder condition (PPBC). All instruments were
validated in the local language. Further details
about each scale are included in Appendix 3 in
the online supplementary material.
Presence of LUTS was defined as the presence
of voiding, storage, or post-micturition symp-
tom(s) with a frequency of at least one in five
times. This was in accordance with ICS criteria,
except that nocturia was defined as at least two
episodes per night during the preceding month
(the ICS definition of at least one episode per
night could lead to an artificially high LUTS
prevalence in the general population) [1].
Additional information was collected, such as
comorbidities, visits to healthcare professionals,
and current medication.
The primary objective was to determine
LUTS prevalence in the population aged at least
40 years, in China, Taiwan, and South Korea,
using ICS 2002 symptom definition (presence of
at least one of voiding, storage, or post-mic-
turition symptoms) [1]. Secondary objectives
included assessment of the symptom-specific
bother of LUTS and exploration of the
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differences in prevalence of LUTS across men
and women, age groups, different socioeco-
nomic strata, and countries.
Statistical Analysis
To estimate the proportion of patients with a
given response to LUTS to a precision of five
percentage points, it was calculated that at least
384 respondents per group was needed. For
analysis of five age groups, a minimum sample
size of 1920 per country (5760 in total) was
required. Assuming that approximately 28% of
data would be non-evaluable due to missing or
inconsistent information, total enrollment of
8000 respondents was planned across the three
countries.
The initial data analyses were based on
descriptive statistics. Post-stratification weight-
ing matched the population distribution (age
and sex) per country. Post hoc statistical com-
parisons were based on the Chi square test, with
the exception of differences in LUTS prevalence
(based on ICS criteria) according to work status,
which were assessed using Fisher’s exact test.
The Spearman method was used to investigate
the relationship between IPSS and PPBC.
RESULTS
Survey Sample
The survey sample and response rate are pro-
vided in Table S1 in the online supplementary
material. Of the 8284 survey participants, 50.8%
were women and 34.4% were aged at least
60 years (Table 1). Most respondents (approxi-
mately 90%) answered all of the questions.
Overall Prevalence
The overall prevalence of LUTS according to ICS
criteria was 61.2% (Fig. 1). Prevalence in South
Korea (68.2%) was higher than in China
(59.0%) or Taiwan (58.5%) (p = 0.001). In par-
ticipants with LUTS, the most common combi-
nation of ICS symptom groups was all three
groups (35.0%); post-micturition symptoms
only or voiding symptoms only were experi-
enced by 3.0% and 7.3%. Storage symptoms
commonly occurred alone (29.9% of partici-
pants with LUTS).
Prevalence by Demographic
Characteristics
LUTS were more prevalent among men (62.8%)
than women (59.7%) (p = 0.004; Table 2).
Prevalence of storage symptoms only was
higher in women than men (23.8% versus
12.6%, respectively). Conversely, more men
had voiding symptoms only (7.2%) or
post-micturition symptoms only (2.1%) than
women (1.8% and 1.6%, respectively). LUTS
prevalence increased significantly with age from
49.9% (age 40–44 years) to 69.7% (age over
60 years) in the overall population (p = 0.001;
Table 2); this trend was more marked among
women than men in China and Taiwan, but it
was not evident in South Korean participants.
LUTS prevalence was affected by marital and
work status (p = 0.001 for both) but not educa-
tion (Table 2). Marital status with the highest
LUTS prevalence was being a widow or widower
(66.8%) and that with the lowest prevalence
was being single (54.1%). Regarding work sta-
tus, LUTS prevalence was highest among per-
manently disabled individuals or those unable
to work because of ill health (84.6%), and low-
est among students (48.8%).
Prevalence by Comorbid Conditions
All comorbid conditions analyzed were associ-
ated with statistically significantly increased
LUTS prevalence (p B 0.001; Fig. S1 in the
online supplementary material). Diabetes and
neurological disease were associated with the
greatest increases in LUTS prevalence between
individuals with and without the comorbidity
(differences of 26.5% and 26.1%, respectively).
Prevalence of Symptoms and Associated
Bother
Symptoms with the highest overall prevalence
were nocturia, frequency, incomplete
Adv Ther
Table 1 Participants’ demographic data
China
(n5 4136) (%)
Taiwan
(n 5 2068) (%)
South Korea
(n5 2080) (%)
Overall
(n5 8284) (%)
Sex
Men 50.3 48.6 47.6 49.2
Women 49.7 51.4 52.4 50.8
Age group
40–44 years 19.9 15.6 16.9 18.1
45–49 years 19.6 16.1 16.8 18.0
50–54 years 15.3 16.3 16.3 15.8
55–59 years 12.7 14.9 14.4 13.7
C60 years 32.6 37.1 35.6 34.4
Education
High-school or less 28.0 39.3 30.3 31.4
Some college 28.4 23.7 3.4 20.9
College degree/college graduate 40.2 28.2 57.0 41.4
Postgraduate 3.5 8.8 9.4 6.3
Marital status
Single 2.9 14.9 9.2 7.5
Divorced 1.5 5.2 4.0 3.0
Married/living with partner 91.7 72.8 81.6 84.5
Widow/widower 3.2 6.3 4.5 4.3
Prefer not to answer 0.8 0.7 0.7 0.7
Work status
Homemaker 2.6 12.0 22.4 9.9
Retired 28.7 16.9 6.0 20.1
Student 0.0 0.1 0.2 0.1
Working, full-time 62.6 60.0 53.9 59.8
Working, part-time 3.7 6.2 8.0 5.4
Other work for pay 0.4 0.8 3.2 1.2
Other 1.1 1.9 3.7 2.0
Unemployed 0.6 1.3 2.3 1.2
Permanently disabled/cannot work
because of ill health
0.1 0.8 0.4 0.4
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emptying, and terminal dribble (Fig. 2). Symp-
toms with the largest numbers of patients
experiencing ‘‘quite a bit or greater’’ bother were
terminal dribble, nocturia, and urgency. Preva-
lence of nocturia (at least two episodes per
night) and extent of associated bother differed
little between men and women, with preva-
lence of 35% and 37% and percentages with
‘‘quite a bit or greater’’ bother of 25% and 26%,
respectively.
According to IPSS, 86.8% of participants had
at least mild symptoms (Fig. S2 in the online
supplementary material), which was similar
across all three countries. Moderate or greater
symptoms were reported in 34.0% of respon-
dents and were more common in those aged
55–60 years and over 60 years (39.8% and
43.2%, respectively) than in younger age groups
[range 22.9% (respondents aged 40–44 years) to
29.5% (those aged 50–54 years)]. This difference
across age groups was statistically significant
(p = 0.001). Increasing IPSS symptom severity
was associated with worsening PPBC (Table S2
in the online supplementary material; Spear-
man correlation coefficient 0.734; p = 0.001):
60% of participants with severe IPSS had mod-
erate or greater problems according to PPBC.
This pattern was evident among men and
women, and across the three countries.
Healthcare Seeking
Twenty-six percent of individuals with any
LUTS according to ICS criteria reported visiting
healthcare professionals during the previous
12 months because of urinary symptoms. Indi-
viduals with voiding, storage, and post-mic-
turition symptoms (45%) had the highest
healthcare professional consultation rate
(Fig. S3 in the online supplementary material),
with the difference versus other ICS symptom
groups reaching statistical significance
(p = 0.001). The lowest rate was in participants
with voiding symptoms only. The percentage of
individuals who had visited healthcare profes-
sionals because of urinary symptoms increased
with IPSS severity (p = 0.001), from 8% (mild) to
63% (severe). A slightly higher rate of health-
care professional consultation was observed in
women versus men with LUTS (27% vs. 25%
[not statistically significant]). Fifty-nine percent
of individuals with LUTS according to ICS cri-
teria were following treatment (Table S3 in the
online supplementary material). There were
statistically significant differences between ICS
symptom groups in this respect (p = 0.001), and
the category with the highest percentage of
individuals following treatment was voiding
plus storage plus post-micturition symptoms
(78%).
DISCUSSION
Overall, 61% of participants in this study (in-
dividuals aged at least 40 years from China,
Taiwan, and South Korea) fulfilled the ICS cri-
teria for LUTS, and bothersome symptoms were
common. Over one-third of men and women
with LUTS reported all three ICS symptom
groups. LUTS prevalence was slightly higher in
men than women and tended to increase with
increasing age. Only half of individuals with
symptoms in all three ICS categories had con-
sulted healthcare professionals about these
symptoms. Our results confirm that in three
Asian countries there is a lack of patient
PM (1.9%) 
PM+S (2.8%) 
V (4.5%)
V+PM (2.3%)
V+S+PM
(21.4%)
V+S
(10.0%)
S (18.3%) 
No LUTS (38.8%) 
Fig. 1 Prevalence of LUTS according to ICS symptom
deﬁnitions (overall population, N = 8284). In total, 61.2%
of patients had any LUTS. ICS International Continence
Society, LUTS lower urinary tract symptoms, PM
post-micturition symptoms, S storage symptoms, V voiding
symptoms
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awareness of LUTS and an unmet need for its
diagnosis and treatment, resulting in a signifi-
cant health burden, as previously noted in
Western studies.
LUTS prevalence varied according to work
and marital status. Among individuals who are
disabled or unable to work because of ill health,
LUTS could be related to detrusor overactivity
caused by neurological conditions [12]. High
prevalence among widows/widowers and low
prevalence among students may be
attributable to age differences in these groups
versus the overall population. Potential con-
tributors to variability between countries
include genetic/ethnicity differences (affecting
susceptibility to LUTS), and cultural/linguistic
differences (affecting the way study questions
were answered) [13, 14].
The present LUTS prevalence data appear
broadly comparable with population-based
studies performed in Europe and North America
[8, 9]. However, in these studies, LUTS preva-
lence appears to be higher in women than men,
while we found the opposite was true. In the
EPIC study, conducted in over 19,000 individ-
uals aged at least 18 years, LUTS prevalence was
64.3% (men 62.5%; women 66.6%) [9]. The
EpiLUTS study (30,000 participants aged at least
40 years) reported LUTS in 72.3% of men and
76.3% of women [8]. As in the present study,
ICS criteria were used but direct comparisons
are confounded by other differences (e.g.,
demographics, definition of nocturia).
Although no previous international popula-
tion-based studies have investigated LUTS
prevalence in Asia using ICS criteria, previous
studies have reported LUTS prevalence in
China, South Korea, and Taiwan [10, 11, 15–21];
prevalence rates greater than 50%, consistent
with our results, have been reported in China
[11, 18, 21] and South Korea [10, 20]. One
Chinese study involved 3023 participants aged
at least 18 years who completed the Interna-
tional Consultation on Incontinence Ques-
tionnaire Male/Female Lower Urinary Tract
Symptoms Long Form [11], while the other two
used the Bristol Female Lower Urinary Tract
Symptoms questionnaire in women aged at
least 40 years [18] and those aged at least
20 years with selected LUTS symptoms [21].T
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Participants of one of the South Korean studies
were men and women aged at least 18 years,
and LUTS prevalence was based on ICS criteria
with a nocturia cutoff of at least one episode per
night [10], while the second study involved
men aged at least 40 years, with LUTS preva-
lence determined using ICS criteria and noc-
turia defined as at least two episodes per night
[20]. In the remaining four studies, three of
which were conducted using the IPSS, LUTS
prevalence rates below 30% were reported
[15–17, 19]. The extent of variability might be
related to differences between countries in
clinical practice, the use of different assessment
techniques (e.g., one study assessed only uri-
nary frequency [15]), or small sample sizes. Also,
in three of the low-prevalence studies, LUTS was
assessed using IPSS; although this scale was
originally validated for assessing male LUTS, it
has subsequently been validated in women,
including Asian women [22, 23]. While it may
be helpful to determine severity of LUTS, the
IPSS does not evaluate incontinence or
post-micturition symptoms, and storage and
emptying symptoms do not necessarily reflect
disorders of storage and voiding function [24].
Hence, data based on the IPSS are often evalu-
ated in conjunction with those from other
assessment tools.
Approximately three-quarters of individuals
with LUTS did not visit a healthcare profes-
sional in relation to their symptoms and LUTS
was untreated in 41% of cases. The reasons for
low consultation rates are varied, but they may
be attributable to stigma, beliefs that LUTS
occur naturally with ageing, and perceptions
that LUTS are not curable or treatable [25–27].
The belief that symptoms are a minor problem
may also affect the need to seek help [25];
indeed in Chinese women with urinary incon-
tinence, seeking professional help was associ-
ated more with the perceived level of bother
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than with symptom severity [27]. Among indi-
viduals with LUTS, a slightly higher percentage
of women than men reported visiting health-
care professionals because of urinary symptoms.
This difference could be related to an increased
frequency of visits to healthcare professionals
for any reason among women. There is a need
to encourage increased uptake of healthcare for
LUTS, to reduce the impact on individuals’ QoL.
Pharmacoeconomic analysis is beyond the
scope of this study, but untreated LUTS have
financial as well as QoL effects (e.g., decreased
workplace productivity) [28].
Potential strengths of our study include the
large sample size, well-balanced demographic
characteristics (e.g., similar numbers of men
and women), and a comparison between three
countries. The instruments used in our study
are well established and validated
[22, 23, 29–31]. Conducting the study via the
Internet was cost-efficient and suitable for ask-
ing questions of a sensitive or personal nature.
However, this approach may result in bias by
only including individuals with Internet access.
We selected China, South Korea, and Taiwan on
the basis of the highest Internet penetration
rates within Asia in 2015 (50%, 92%, and 84%,
respectively) [32]. National statistics suggest
that our study may be biased towards individ-
uals of a higher socioeconomic class, particu-
larly those with a higher educational level
[33–36], although income was more aligned
[37–39]. This is unsurprising given the different
populations and cutoff points between our
study and national statistics. Nevertheless, a
survey on Internet development in China
reported that 22.1% of those using the Internet
used online medical services, the most common
of which was seeking healthcare information
before seeing a doctor [40]. This suggests that
the Internet may have a considerable impact on
general health and healthcare. Further potential
disadvantages were the use of a consumer panel,
which is prone to volunteer bias, restriction to
urban areas, and the lack of background data to
allow more detailed analysis of the results.
Nevertheless, we feel that the data emphasize
important epidemiological messages that set
the scene for further work and more detailed
pharmacoepidemiological research across the
region.
CONCLUSIONS
LUTS are present in the majority of men and
women aged at least 40 years in China, Taiwan,
and South Korea. Bothersome storage symp-
toms (the OAB symptom complex) are com-
mon, occurring in at least 50% of those with
LUTS, and LUTS prevalence increases with
increasing age. Comorbid conditions, particu-
larly diabetes and neurological disease, are
associated with increased risk of LUTS. Only
26% of individuals with LUTS seek healthcare
and our results suggest there is a need for
increased patient awareness of LUTS, its diag-
nosis, and treatment.
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